Letrozole (Femara)

What is Letrozole?

Letrozole, also known as Femara, is a potent reversible aromatase inhibitor widely utilized by steroid users to manage estrogen-related side effects resulting from the use of aromatizing steroids. Compared to other aromatase inhibitors like Arimidex and Aromasin, Letrozole is recognized as the most powerful nonsteroidal AI available.

Highly favored by users of popular aromatizing steroids such as Testosterone and Dianabol, Letrozole effectively reduces estrogen levels by blocking the aromatase enzyme. Unlike Selective Estrogen Receptor Modulators (SERMs) that target specific areas of the body, Letrozole offers comprehensive estrogen control, combating a broad spectrum of estrogenic side effects, particularly gynecomastia and water retention, thus helping prevent associated high blood pressure.

The exceptional potency of Letrozole allows some users to successfully reverse gynecomastia effects, emphasizing its effectiveness at even low doses. Its robust action in controlling estrogen levels underscores its value in managing estrogen-related concerns among steroid users.

Recommended Dosage:
For Men: 0.5-2.5mg every other day during a steroid cycle to address elevated estrogen levels. The duration of Letrozole use depends on the specific steroid cycle being followed. In cases where Letrozole is used to combat gynecomastia, a dosage of 2.5mg every other day is suggested until improvement is observed.
For Women: While estrogen concerns are less significant for female steroid users compared to males, Letrozole may be utilized to manage water retention, especially in competitive bodybuilding or physique competitions. Due to its potent estrogen reduction effects, Letrozole is not the primary choice for females who have not undergone menopause. If used, a starting dose of 0.5mg every other day is recommended, with adjustments made based on individual response and effects.